Medications for attention-deficit/hyperactivity disorder in Japan: A retrospective cohort study of label compliance.
Saved in:
| Title: | Medications for attention-deficit/hyperactivity disorder in Japan: A retrospective cohort study of label compliance. |
|---|---|
| Authors: | Fife D; Department of Epidemiology, Janssen Research & Development, LLC, Titusville, NJ, USA., Voss EA; Department of Epidemiology, Janssen Research & Development, LLC, Titusville, NJ, USA., Hardin J; Department of Epidemiology, Janssen Research & Development, LLC, Titusville, NJ, USA., Rofael H; Established Products, Janssen Research & Development, LLC, Titusville, NJ, USA., Solomon ID; Established Products, Janssen Research & Development, LLC, Titusville, NJ, USA., Ryan PB; Department of Epidemiology, Janssen Research & Development, LLC, Titusville, NJ, USA., Stang P; Department of Epidemiology, Janssen Research & Development, LLC, Titusville, NJ, USA. |
| Source: | Neuropsychopharmacology reports [Neuropsychopharmacol Rep] 2021 Sep; Vol. 41 (3), pp. 385-392. Date of Electronic Publication: 2021 Jun 28. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101719700 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2574-173X (Electronic) Linking ISSN: 2574173X NLM ISO Abbreviation: Neuropsychopharmacol Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2574-173X |
|---|---|
| DOI: | 10.1002/npr2.12191 |
